SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001891
Filing Date
2024-11-12
Accepted
2024-11-12 17:00:32
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20240930x10q.htm   iXBRL 10-Q 2104520
2 EX-31.1 snpx-20240930xex31d1.htm EX-31.1 9698
3 EX-31.2 snpx-20240930xex31d2.htm EX-31.2 9760
4 EX-32.1 snpx-20240930xex32d1.htm EX-32.1 5001
5 EX-32.2 snpx-20240930xex32d2.htm EX-32.2 5084
  Complete submission text file 0001410578-24-001891.txt   7408631

Data Files

Seq Description Document Type Size
6 EX-101.SCH snpx-20240930.xsd EX-101.SCH 61061
7 EX-101.CAL snpx-20240930_cal.xml EX-101.CAL 32376
8 EX-101.DEF snpx-20240930_def.xml EX-101.DEF 254095
9 EX-101.LAB snpx-20240930_lab.xml EX-101.LAB 451176
10 EX-101.PRE snpx-20240930_pre.xml EX-101.PRE 358659
62 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20240930x10q_htm.xml XML 936619
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 241449591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)